These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16933092)

  • 1. Ionization states in the microenvironment of solid dosage forms: effect of formulation variables and processing.
    Govindarajan R; Zinchuk A; Hancock B; Shalaev E; Suryanarayanan R
    Pharm Res; 2006 Oct; 23(10):2454-68. PubMed ID: 16933092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-state surface acidity and pH-stability profiles of amorphous quinapril hydrochloride and silicate formulations.
    Hailu SA; Bogner RH
    J Pharm Sci; 2010 Jun; 99(6):2786-99. PubMed ID: 20091829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface acidity of solid pharmaceutical excipients III. Excipients for solid dosage forms.
    Scheef CA; Oelkrug D; Schmidt PC
    Eur J Pharm Biopharm; 1998 Sep; 46(2):209-13. PubMed ID: 9795064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microenvironmental pH modulation in solid dosage forms.
    Badawy SI; Hussain MA
    J Pharm Sci; 2007 May; 96(5):948-59. PubMed ID: 17455349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate drug release from solid oral dosage forms.
    Schreiner T; Schaefer UF; Loth H
    J Pharm Sci; 2005 Jan; 94(1):120-33. PubMed ID: 15761936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of solid dosage form composition through drug-excipient compatibility testing.
    Serajuddin AT; Thakur AB; Ghoshal RN; Fakes MG; Ranadive SA; Morris KR; Varia SA
    J Pharm Sci; 1999 Jul; 88(7):696-704. PubMed ID: 10393567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation.
    Airaksinen S; Karjalainen M; Kivikero N; Westermarck S; Shevchenko A; Rantanen J; Yliruusi J
    AAPS PharmSciTech; 2005 Oct; 6(2):E311-22. PubMed ID: 16353990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface acidity and solid-state compatibility of excipients with an acid-sensitive API: case study of atorvastatin calcium.
    Govindarajan R; Landis M; Hancock B; Gatlin LA; Suryanarayanan R; Shalaev EY
    AAPS PharmSciTech; 2015 Apr; 16(2):354-63. PubMed ID: 25319055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Microenvironmental Acidity: A Strategy to Mitigate Salt Disproportionation in Drug Product Environment.
    Koranne S; Lalge R; Suryanarayanan R
    Mol Pharm; 2020 Apr; 17(4):1324-1334. PubMed ID: 32142293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms.
    Badawy SI; Williams RC; Gilbert DL
    J Pharm Sci; 1999 Apr; 88(4):428-33. PubMed ID: 10187753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Metallic Stearates on Disproportionation of Hydrochloride Salts of Weak Bases in Solid-State Formulations.
    Nie H; Xu W; Ren J; Taylor LS; Marsac PJ; John CT; Byrn SR
    Mol Pharm; 2016 Oct; 13(10):3541-3552. PubMed ID: 27542728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry coating, a novel coating technology for solid pharmaceutical dosage forms.
    Luo Y; Zhu J; Ma Y; Zhang H
    Int J Pharm; 2008 Jun; 358(1-2):16-22. PubMed ID: 18467045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of presence of excipients in drug analysis in fed-state gastric biorelevant media.
    Baxevanis F; Kuiper J; Fotaki N
    Eur J Pharm Biopharm; 2018 Oct; 131():178-188. PubMed ID: 30110669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sertraline salt form on the oxidative stability in powder blends.
    Hsieh YL; Yu W; Xiang Y; Pan W; Waterman KC; Shalaev EY; Shamblin SL; Taylor LS
    Int J Pharm; 2014 Jan; 461(1-2):322-30. PubMed ID: 24325937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of freeze-drying on ionization of sulfonephthalein probe molecules in trehalose-citrate systems.
    Govindarajan R; Chatterjee K; Gatlin L; Suryanarayanan R; Shalaev EY
    J Pharm Sci; 2006 Jul; 95(7):1498-510. PubMed ID: 16721795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Photoreactive Excipient to Probe Peptide-Matrix Interactions in Lyophilized Solids.
    Chen Y; Topp EM
    J Pharm Sci; 2020 Jan; 109(1):709-718. PubMed ID: 31034909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.